| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021551434 |
| P356 | DOI | 10.1007/S15027-013-0021-2 |
| P932 | PMC publication ID | 3660235 |
| P698 | PubMed publication ID | 23642232 |
| P2093 | author name string | Feng Liu | |
| Xiang Li | |||
| Yi Song | |||
| Chong Zhao | |||
| Rui Yu | |||
| Zhaohui Meng | |||
| Haibo Wan | |||
| Runwei Ma | |||
| Qiufang Ye | |||
| Jianxion Wen | |||
| Shao Ban | |||
| Yuehui Xie | |||
| P2860 | cites work | Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. | Q52539773 |
| Association of smooth muscle cell phenotypes with extracellular matrix disorders in thoracic aortic dissection. | Q52629543 | ||
| Up-regulation of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase were coupled with that of type I procollagen in granulation tissue response after the onset of aortic dissection. | Q53627905 | ||
| Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. | Q54284525 | ||
| Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers | Q57075223 | ||
| Localization of Aortic Disease Is Associated with Intrinsic Differences in Aortic Structure | Q71944654 | ||
| Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases | Q71971790 | ||
| Atherosclerosis of the aorta in patients with acute thoracic aortic dissection | Q82194361 | ||
| The prominent expression of plasma matrix metalloproteinase-8 in acute thoracic aortic dissection | Q84737477 | ||
| Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages | Q24318771 | ||
| Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms | Q24564318 | ||
| Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor | Q27635061 | ||
| Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology | Q28140467 | ||
| Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase | Q28235879 | ||
| Cardiorenal end points in a trial of aliskiren for type 2 diabetes | Q28278569 | ||
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 | ||
| Synthetic active site-directed inhibitors of metzincins: achievement and perspectives | Q31165313 | ||
| Rule out of acute aortic dissection with plasma matrix metalloproteinase 8 in the emergency department | Q33753908 | ||
| MMP12, lung function, and COPD in high-risk populations | Q33994495 | ||
| 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideli | Q34104296 | ||
| Mouse macrophage elastase. Purification and characterization as a metalloproteinase | Q34276457 | ||
| Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. | Q34542211 | ||
| Gene expression in acute Stanford type A dissection: a comparative microarray study | Q35011911 | ||
| Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions | Q35187788 | ||
| Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms | Q35765078 | ||
| Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects | Q35826397 | ||
| Carotid atherosclerotic plaque matrix metalloproteinase-12-positive macrophage subpopulation predicts adverse outcome after endarterectomy | Q36519765 | ||
| Matrix metalloproteinases in peripheral vascular disease | Q36776164 | ||
| Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors | Q36879377 | ||
| Progress in the development of matrix metalloproteinase inhibitors | Q37184951 | ||
| Pathway analysis of differentially expressed genes in patients with acute aortic dissection. | Q37277608 | ||
| Aliskiren versus ramipril in hypertension | Q37736951 | ||
| Matrix metalloproteinases and cardiovascular disease | Q40410789 | ||
| Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin | Q41486787 | ||
| Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers | Q41955134 | ||
| Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension pha | Q44970265 | ||
| Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats | Q45232287 | ||
| Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension | Q46289193 | ||
| Aliskiren combined with losartan in type 2 diabetes and nephropathy | Q46558669 | ||
| Acute aortic dissection in China | Q47419064 | ||
| Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics | Q47792492 | ||
| Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection | Q48003795 | ||
| Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. | Q52037368 | ||
| P304 | page(s) | 34 | |
| P577 | publication date | 2013-05-03 | |
| P1433 | published in | BMC Cardiovascular Disorders | Q15753126 |
| P1476 | title | Expression of matrix metalloproteinase-12 in aortic dissection | |
| P478 | volume | 13 |
| Q47134795 | Association of serum cystatin C levels with mortality in patients with acute type A aortic dissection |
| Q64058077 | Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation |
| Q41772435 | Differentially expressed genes and canonical pathways in the ascending thoracic aortic aneurysm - The Tampere Vascular Study |
| Q47111390 | Expression of matrix metalloproteinases-12 in ST-segment elevation myocardial infarction: A case-control study |
| Q89829975 | Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm |
Search more.